SCHEMBL13598262

SCHEMBL13598262

COC1=C(CO)C(=O)C(CC=C(C)C)=C(C)C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.58
▸ MAPT P10636 5/20 0.45
▸ PGR P06401 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ PDE3A Q14432 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ MAOA P21397 1/20 0.45
▸ TBXA2R P21731 1/20 0.45
▸ AVPR2 P30518 1/20 0.45
▸ HTR2B P41595 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SIRT2 Q8IXJ6 1/20 0.45
▸ SLC29A1 Q99808 1/20 0.45
▸ MAOB P27338 2/20 0.42
▸ HTR1A P08908 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14407311 0.88 LMNA (0.58) LMNAMAPTPGRMAPK1PDE3A
Coenzyme Q1 SCHEMBL1129498 0.87 LMNA (0.73) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL13598263 0.87 LMNA (0.54) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL14407307 0.85 LMNA (0.62) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL441634 0.83 MAOB (0.49) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL14407312 0.82 MAPT (0.56) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL14407313 0.82 LMNA (0.62) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL13431190 0.77 MAPT (0.49) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL14407281 0.76 LMNA (0.56) LMNAMAPTPGRMAPK1PDE3A
SCHEMBL16999349 0.75 LMNA (0.62) LMNAMAPTPGRMAPK1PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE ENGELS PETER 2009-12-31 — — US disclosed
US-20090041700-A1 COMPOSITION FOR PERMANENT SHAPING HUMAN HAIR KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2009-02-12 — — US disclosed
US-20080193432-A1 Compounds Having Estrogenic Activity NATIONAL TAIWAN UNIVERSITY (TW) 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193432-A1 Compounds Having Estrogenic Activity ESRRA, ESRRG, ESR2 LMNA 3680/4885MAPT 4404/4885PGR 30/4885
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE CUTA, BROX, MANBA LMNA 1248/4885MAPT 497/4885PGR 3508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback